TIL earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Hold, P/E -1.02. Updated 2026-07-23.
Instil Bio (TIL) Research Hub
Instil Bio (TIL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 7.38 USD (-2.64%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.02, market cap 0.05B. This hub links to the full technical, earnings and options research available for TIL.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 7.38 USD (-2.64%) |
| 52-week range | 7.02 USD – 8.08 USD |
| Trend regime | Range |
| 14-day RSI | 49.3 (Neutral) |
| Trailing P/E | -1.02 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for TIL
Covered Call on TIL: how it works, illustrative setup around the real 7.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TIL: how it works, illustrative setup around the real 7.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TIL: how it works, illustrative setup around the real 7.38 USD price, max profit/loss, breakeven and when to use it. Educational.
TIL technical analysis: range, last 7.38 USD, RSI 49.3, 52w range 7.02 USD–8.08 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TIL in?
Instil Bio (TIL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TIL in an uptrend or downtrend?
As of 2026-09-11, TIL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TIL's trailing P/E ratio?
TIL's trailing P/E is -1.02, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does TIL next report earnings?
TIL is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.35 USD.